NASDAQ:EDIT

Editas Medicine Stock Forecast

etoro logo Buy EDIT
*Your capital is at risk
$2.58
-0.0200 (-0.769%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of EDIT
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Editas Medicine, Inc stock upgraded to Hold/Accumulate
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Nov 17, 2025

The Editas Medicine, Inc stock price fell by -0.769% on the last day (Monday, 17th Nov 2025) from $2.60 to $2.58. During the last trading day the stock fluctuated 6.79% from a day low at $2.51 to a day high of $2.68. The price has fallen in 5 of the last 10 days and is down by -15.69% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -538 thousand shares and in total, 1 million shares were bought and sold for approximately $3.17 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.51 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 12.00% during the next 3 months and, with a 90% probability hold a price between $2.82 and $4.88 at the end of this 3-month period.

EDIT Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, November 07, 2025, and so far it has risen 4.45%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Editas Medicine, Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.58 and $3.35. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Editas Medicine, Inc stock

Editas Medicine, Inc finds support from accumulated volume at $2.54 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.170 between high and low, or 6.79%. For the last week, the stock has had daily average volatility of 8.35%.

Our recommended stop-loss: $2.45 (-5.21%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (EDIT) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Editas Medicine, Inc to open at $2.59, and during the day (based on 14 day Average True Range), to move between $2.45 and $2.71, which gives a possible trading interval of +/-$0.268 (+/-10.97%) up or down from last closing price. If Editas Medicine, Inc takes out the full calculated possible swing range there will be an estimated 10.97% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.54 (1.55%) than the resistance at $2.83 (9.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Editas Medicine, Inc stock A Buy?

Editas Medicine, Inc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.348 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $2.59 ( 0.258%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

EDIT Performance

Trading levels for EDIT

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.76 6.85%
R2 2.69 4.33%
R1 2.65 2.78%
Price 2.58
S1 2.52 -2.26%
S2 2.48 -3.81%
S3 2.42 -6.33%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.08 19.38%
R2 3.00 16.28%
R1 2.83 9.69%
Price 2.58
S1 2.54 -1.55%
S2 2.52 -2.33%
S3 2.47 -4.26%

FAQ

What is the symbol for Editas Medicine, Inc Stock and on which exchange is it traded?
The symbol for Editas Medicine, Inc is EDIT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Editas Medicine, Inc Stock?
Editas Medicine, Inc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Editas Medicine, Inc Stock?
Editas Medicine, Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Editas Medicine, Inc Stock.

What's the current price of Editas Medicine, Inc Stock?
As of the end of day on the Nov 17, 2025, the price of an Editas Medicine, Inc (EDIT) share was $2.58.

What is the 52-week high and low for Editas Medicine, Inc Stock?
The 52-week high for Editas Medicine, Inc Stock is $4.54 and the 52-week low is $0.91.

What is the market capitalization of Editas Medicine, Inc Stock?
As of the Nov 17, 2025, the market capitalization of Editas Medicine, Inc is 219.575M.

When is the next earnings date for Editas Medicine, Inc?
The upcoming earnings date for Editas Medicine, Inc is Mar 04, 2026.
Click to get the best stock tips daily for free!
ABOUT EDITAS MEDICINE, INC
Editas Medicine
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads to inherited childhood blindness. It also develops EDIT-102 for the treatment of Usher Syndrome 2A, whic...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE